Harvard Scientists Have Developed a Revolutionary New Treatment for Diabetes

External News Details

A group of researchers from the University of MissouriGeorgia Institute of Technology, and Harvard University has proved the successful use of a novel Type 1 diabetes treatment in a large animal model in a new study published in Science Advances. Their method includes transferring insulin-producing pancreas cells, known as pancreatic islets, from a donor to a recipient without the need for long-term immunosuppressive medicines. The Georgia Tech team includes Andres Garcia, executive director of the Parker H. Petit Institute for Bioengineering and Biosciences (IBB);  María M. Coronel, IBB postdoctoral fellow; and Michael Hunckler, bioengineering Ph.D. candidate. 

Additional Information


College of Sciences, School of Biological Sciences

Biotechnology, Health, Bioengineering, Genetics
College of Sciences, Parker H. Petit Institute for Bioengineering and Biosciences, Andres Garcia, María M. Coronel, Michael Hunckler, Diabetes, Type I diabetes, pancreatic islets, insulin
  • Created By: Renay San Miguel
  • Workflow Status: Published
  • Created On: Jun 14, 2022 - 3:14pm
  • Last Updated: Jun 14, 2022 - 3:14pm